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ABSTRACT
Objective: Assessment of disease extension and activity
is crucial to guide treatment in Crohn’s disease. The
objective of the current cross-sectional study was to
determine the accuracy of MR for this assessment.
Design: 50 patients with clinically active (n = 35) or
inactive (n = 15) Crohn’s disease underwent ileocolono-
scopy (reference standard) and MR. T2-weighted and
precontrast and postcontrast-enhanced T1-weighted
sequences were acquired. Endoscopic activity was
evaluated by CDEIS (Crohn’s Disease Endoscopic Index of
Severity); in addition endoscopic lesions were classified
as absent, mild (inflammation without ulcers) or severe
(presence of ulceration).
Results: The comparison of intestinal segments with
absent, mild and severe inflammation demonstrated a
progressive and significant (p,0.001) increase in the
following MR parameters: wall thickness, postcontrast
wall signal intensity, relative contrast enhancement,
presence of oedema, ulcers, pseudopolyps and lymph
node enlargement. Independent predictors for CDEIS in a
segment were wall thickness (p = 0.007), relative
contrast enhancement (p = 0.01), presence of oedema
(p = 0.02) and presence of ulcers at MR (p = 0.003).
There was a significant correlation (r = 0.82, p,0.001)
between the CDEIS of the segment and the MR index
calculated according to the logistic regression analysis
coefficients. The MR index had a high accuracy for the
detection of disease activity (area under the receiver
operating characteristic (ROC) curve 0.891, sensitivity
0.81, specificity 0.89) and for the detection of ulcerative
lesions (area under the ROC curve 0.978, sensitivity 0.95,
specificity 0.91) in the colon and terminal ileum.
Conclusion: The accuracy of MR for detecting disease
activity and assessing severity brings about the possibility
of using MR as an alternative to endoscopy in the
evaluation of ileocolonic Crohn’s disease.
Assessment of disease extension and activity is
crucial in patients with Crohn’s disease (CD) to
determine the therapeutic strategy, and has impor-
tant prognostic implications. This assessment
usually relies on endoscopy.1 However, endoscopy
cannot always be complete, and there are several
drawbacks related to the invasiveness, procedure-
related discomfort, risk of bowel perforation and
relatively poor patient acceptance. This fact has led
to the search for alternative techniques to assess
disease extension and severity in inflammatory
bowel disease (IBD) including sonography and
CT.2 Exposure to ionising radiation is a relevant
limitation of the latter, especially in light of the
patients’ young age.3 We and others have proposed
the use of sonography for evaluation of IBD
activity as an alternative to endoscopy, but
assessment of the intestine by this technique is
frequently incomplete due to gas interposition.4
Magnetic resonance (MR) has the potential to
overcome these limitations. It is characterised by a
very high soft tissue contrast, lack of ionising
radiation and lower incidence of adverse events
related to the intravenous contrast employed
compared with CT. Although several MR char-
acteristics of the bowel have been described in
patients with CD, no studies have specifically
addressed the relative usefulness of each of these
MR signs in the assessment of inflammatory
activity and severity, and most protocols relied
only on measurement of wall thickness and degree
of enhancement after administration of paramag-
netic contrast. Using the latter parameters, some
previous reports5–9 produced controversial results,
and methodological differences make comparisons
difficult. Despite its potential usefulness, a major
drawback to the routine use of MR in the
assessment of CD is the lack of precise criteria to
define bowel involvement by CD, and quantify the
severity of inflammatory lesions.
Therefore, the aims of this cross-sectional study
were to characterise the MR patterns of the colon
and the terminal ileum in patients with active and
inactive CD; to establish the MR changes indica-
tive of mild and severe intestinal lesions; and to
provide a quantitative index of disease activity
based on MR findings.
PATIENTS AND METHODS
Patients and examinations
Between June 2007 and April 2008, 50 patients
with an established diagnosis of CD of at least
6 months duration, with or without clinical
symptoms of activity, were prospectively studied
at a single centre. During the same period, two
patients refused to participate in the study because
of personal reasons: one patient preferred to avoid
MR exploration due to claustrophobia, and in
another patient MR examination could not be
completed due to intolerance of the enema.
Patients underwent complete clinical assessment,
had blood samples obtained for cell blood counts
and C-reactive protein (CRP) measurements, and
underwent conventional ileocolonoscopy and MR
examination within 2 days. Clinical disease activity
was assessed using the Harvey–Bradshaw score.10
Investigators performing ileocolonoscopy or MR
were unaware of clinical data or of the results of
other examinations. All patients gave their
informed consent to participate in the study after
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approval of the project by the ethics committee of the Hospital
Clı´nic of Barcelona.
Endoscopic data collection
Ileocolonoscopy was considered the reference standard for the
evaluation of IBD extension and severity. All patients under-
went endoscopy 4–24 h before or after the MR examination.
Patients followed a bowel cleansing protocol with oral ingestion
of 3000–4000 ml of an iso-osmotic polyethylene glycol (PEG)
and electrolyte solution (Bohm laboratories, Fuenlabrada,
Spain) on the evening before examination. Endoscopies were
performed under anaesthesia with propofol (Mayne Pharma,
Madrid, Spain) and remifetanyl (GlaxoSmithKline, Madrid,
Spain). The severity and extent of inflammatory lesions were
evaluated using the Crohn’s Disease Endoscopic Index of
Severity (CDEIS).1 For CDEIS calculation, the endoscopic
variables were as originally defined: deep ulcers and superficial
ulcers (presence or absence), ulcerated surface and affected
surface (evaluated on a 10 cm linear analogue scale), and
ulcerated and non-ulcerated stenosis. These variables were
evaluated in the terminal ileum, ascending colon, transverse
colon, descending and sigmoid colon, and the rectum.
For comparison of endoscopic and MR findings in each
segment, a calculation of endoscopic activity of the segment
was performed by dividing the colon into five segments instead
of four as for the conventional CDEIS calculation (ascending
colon, transverse colon, descending colon, sigmoid colon and
rectum) and scoring the CDEIS variables in each of these
segments and the terminal ileum. The score of ulcerated or non-
ulcerated stenosis was imputed to the affected segment. In
addition, a classification of lesion severity of each segment was
performed by considering three categories: (1) absence of
lesions; (2) presence of inflammatory lesions without ulcera-
tion, including erythema, oedema, pseudopolyps and aphtae;
and (3) presence of superficial or deep ulcerations.
The endoscopist completed an endoscopic scoring sheet
immediately after colonoscopy. All procedures were performed
by two gastroenterologists with .10 years experience in
conventional colonoscopy using standard equipment (CFQ
140 L; Olympus, Japan), and after a period of joint training
for CDEIS scoring.
MR acquisition
In most cases MR and ileocolonoscopy were performed on the
same day, under the bowel cleansing protocol described
previously, without any additional preparation for MR. In the
few instances that the two techniques were not performed on
the same day bowel cleansing with 1000–2000 ml of PEG
solution was given 4 h before performing MR.
All MR examinations were performed using a 3.0 T MR unit
(TrioTim; Siemens Medical Solutions, Erlangen, Germany).
Patients were placed in the supine position in the MR imager.
This position is more comfortable for patients. A combination
of two surface coils was used for signal reception to allow
coverage of the whole abdominal area. To reduce bowel
peristalsis, 40 mg of hyoscine butylbromide (Buscapina;
Boehringer Ingelheim, Sant Cugat, Spain) were injected
intravenously.
To achieve an adequate distension of the distal ileum, 45 min
before the MR each patient was required to drink 1500 ml of
iso-osmotic PEG and electrolyte solution. Saline was retrogradly
instilled into the colon through a flexible rectal balloon catheter
(Silkolater Teleflex Medical, Alicante, Spain). The volume of
warm water was adjusted for each patient to avoid abdominal
pain or discomfort, ranging from 1000 to 2000 ml. The
procedure was well tolerated.
Initially a true fast imaging with a steady precession sequence
was acquired in the coronal plane to ensure optimal colon
distension. Then, the acquisition protocol outlined in table 1
was performed. VIBE (volumetric interpolated breath-hold
examination) sequences were acquired before and 70 s after
intravenous administration of 0.2 ml/kg body weight of
gadolinium chelate (gadodiamide 0.5 mmol/l Ominscan-
Amersham, Madrid, Spain) at a rate of 2 ml/s.
MR image analysis
To establish disease extension by MR, we used the same
division into six segments as was used in colonoscopy (distal
ileum, ascending, transverse, descending, sigmoid colon and
rectum). Image analysis was performed using a dedicated
postprocessing workstation (Leonardo; Siemens AG Medical
Solutions). The following were studied by MR in each colonic
segment and in the terminal ileum: bowel wall thickness
(mm), presence of mucosal ulceration (defined as deep
depressions in the mucosal surface), presence of mural oedema
(hyperintesity on T2-wedged sequences of the colon wall
relative to the signal of the psoas muscle), presence of
pseudopolyps in the lumen, enlarged (.1 cm) regional
mesenteric lymph nodes, quantitative measurement of wall
signal intensity (WSI) before and after intravenous contrast
administration measured in VIBE sequences, and relative
contrast enhancement (RCE) of the intestinal wall.
Quantitative measurements of WSI were obtained from the
areas with the greatest thickening. WSI corresponds to the
average of three WSI measurements. RCE was calculated
according the following formula: RCE = ((WSI postgadoli-
nium–WSI pregadolinium)/(WSI pregadolinium))61006(SD
noise pregadolinium/SD noise postgadolinium), where SD
noise pregadolinium corresponds to the average of three SDs of
the signal intensity measured outside of the body before
gadolinium injection, and SD noise postgadolinium corre-
sponds to the SD of the same noise after gadolinium
administration.11
Statistical analysis
Differences in qualitative MR findings were tested with the x2
test; differences in quantitative measures were tested using
analysis of variance (ANOVA) followed by the Bonferroni
posthoc test. Correlations between the CDEIS, Harvey–
Bradshaw index, CRP and MR index scores were measured by
the Spearman rank coefficient.
For defining the MR findings that were independent
predictors of disease activity, a binary logistic regression was
Table 1 Protocol for MR image acquisition
Plane
Slice
thickness
(mm) FOV TR/TE (ms) Flip angle
True-FISP Coronal 4 4006400 3.46/1.53 50
T2-HASTE
with fat
saturation
Axial 5 3006300 1000/99 150
T2-HASTE Coronal 5 4506450 1200/96 150
VIBE Coronal 1.4 4406440 2.84/1.07 70
FISP, fast imaging with steady precession; FOV, field of view; HASTE, half-Fourier
single-shot turbo spin-echo; TE, echo time; TR, repetition time; VIBE, volumetric
interpolated breath-hold examination.
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used with the presence of an endoscopic lesion (of any type) as
the dependent variable, and with the presence of oedema,
ulcerations, pseudopolyps, wall thickness and RCE in MR as
independent variables. For defining the independent predictors
of the presence of ulcerations at endoscopy, a binary logistic
regression was used, with this endoscopic finding as depen-
dent variable, and the same MR variables listed above as
independent variables. The multivariate procedures were
validated by bootstrap bagging with 1000 samples.
Development of an MR index of disease activity was based
on the findings of the individual segments. Since distribution
of the values for CEDEIS was not normal, with 60% of
segments having no significant lesions, a tobit regression
model was applied. In that model, the calculated CDEIS per
segment was used as the dependent variable, and again the
presence of oedema, ulcerations, pseudopolyps, wall thickness
and RCE in MR were introduced as independent variables. The
accuracy of the scores determined by MR for the prediction of
the presence of active disease and the presence of severe lesions
was assessed by calculating receiver operating characteristic
(ROC) curves.
Interobserver agreement between paired evaluations of MR
by two radiologists (JR and SR) was performed through kappa
statistics12 for comparisons of qualitative variables (presence of
oedema, ulcers, pseudopolyps and lymph nodes), and through
the intraclass correlation coefficient13 for assessing the
reproducibility level of quantitative MR measurements (wall
thickness, basal signal intensity, contrast signal intensity and
RCE).
Statistical power
We estimated that by studying 50 patients at least 200 colonic
segments and 40 ileal segments would be available for
examination (colonoscopy completed in 90% and ileoscopy in
80%). Of those 50% would be normal, 25% would have non-
ulcerative lesions and 25% would have ulcerative lesions. This
number provides the ability to detect differences of 20% for the
presence of activity, and 25% for the presence of ulcerations
among those with disease activity with an alpha risk of 0.05 and
beta of 0.1.
A p value of ,0.05 was considered significant. Calculations
were done with the SPSS package version 15 (SPSS, 1989–2006,
Chicago, Illinois, USA).
RESULTS
Patients
Clinical and biological characteristics of the 50 patients included
in the study are provided in table 2. According to the Harvey–
Bradshaw index, 15 patients were in clinical remission (index
(4) and 35 patients had active disease (index .4). CRP was
elevated relative to reference values (normal (8 mg/l) in 35
patients. Complete endoscopic evaluation of the colon with
intubation of the ileum through the ileocecal valve or an
ileocolonic anastomosis was achieved in 36 patients (72%).
Reasons for incomplete ileocolonoscopy were disease severity
(n = 3), stenosis (n = 3) or technical impossibility (n = 8). The
total number of colonic segments examined, considering the
extension of examinations and previous resection surgery, was
213. Of these, 130 were without lesions, 43 had mild lesions
including erythema, oedema, pseudopolyps or aphtoid ulcers,
and 40 segments had severe lesions with superficial and/or deep
ulcers. Tolerance of MR examination was in general very good.
The average duration of the entire MR examination within the
MR imaging unit was ,25 min. Only three patients, all with
severe rectal lesions, complained of tenesmus upon instillation
of the enema that did not preclude completion of the
examination.
MR findings according to endoscopic lesion severity
As shown in table 3 and fig 1, the majority of MR findings
had a close correlation with the severity of endoscopic lesions.
Oedema on MR examination was present in 77.5% of colonic
segments with ulcers at endoscopy, was significantly less
frequent in segments with inflammatory lesions without
ulcers (20.9%) and absent in endoscopically normal segments.
Ulcers were identified by MR in 65% of patients with ulcers
at endoscopy, were very rare in segments with mild
inflammation (7.0%) and were never observed in endoscopi-
cally normal mucosa. The presence of enlarged lymph nodes
and pseudopolyps was less prevalent, but also significantly
more frequent in patients with ulcers compared with the
other groups of patients (table 3). The kappa measure of
agreement between endoscopy and MR for identification of
ulcers was 0.71, and for pseudopolyps 0.86, although the
sensitivity of MR for the detection of segments with
ulcerative lesions was markedly increased when not only
direct identification of ulcers, but also wall thickening and
REC were considered (see below).
Figure 1 depicts the changes in quantitative MR parameters
according to endoscopic severity of colonic lesions. The increase
in wall thickness paralleled the endoscopic severity of lesions,
with a significant increase in segments with inflammatory
lesions without ulcers compared with those with normal
mucosa, and again significantly increased in segments with
ulcers compared with non-ulcerative inflammatory lesions. In
contrast, basal signal intensity was similar in all groups. After
intravenous injection of contrast, WSI was markedly elevated in
segments with ulceration relative to segments with inflamma-
tion without ulcers, and also in the latter compared with
normal segments. RCE also paralleled the severity of endoscopic
lesions with significant differences between segments with
normal mucosa, segments with mild lesions and segments with
ulcers.
MR changes were similar in all colonic segments, with the
exception of lymph node enlargement that was predominantly
associated with the presence of severe endoscopic lesions in
terminal ileum, ascending colon and rectal regions. The
characteristics and magnitude of MR changes in the ileum were
similar to those of the colon, with significant (p,0.05) increases
in the proportion of patients having oedema, ulcers identified at
MR, and lymph nodes in the ileocecal region, as the severity of
endoscopic lesions increased from normal to presence of any
lesion, and from non-ulcerative lesions to presence of ulcers.
Pseudopolyps were not identified in the ileum. Also a significant
increase in wall thickness, WSI and RCE (all p,0.05 by ANOVA
test), but not basal signal intensity, was observed in the ileum
that paralleled the severity of endoscopic lesions. Examples of
MR alterations associated with the presence of active inflam-
mation are shown in figs 2 and 3.
Interobserver agreement in the evaluation of MR changes was
very high. The kappa index was 0.96 (p,0.001) for the presence
of oedema, 0.87 (p,0.001) for ulcers, 0.92 (p,0.001) for lymph
nodes and 0.85 (p,0.001) for pseudopolyps. The intraclass
correlation coefficients were 0.91 (p,0.001) for wall thickness,
0.73 (p,0.001) for basal signal intensity and 0.93 (p,0.001) for
contrast signal intensity.
Inflammatory bowel disease
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Predictors of disease activity and severity in MR
To determine which of the MR findings had an independent
predictive value for the presence of disease activity at
endoscopy, the presence of ulcers at endoscopy or to predict
the quantitative CDEIS value for a particular segment, the
variable presence of lymph nodes was not introduced in the
regression analyses, because this finding is not uniform in all
anatomical locations. Since there was a highly significant
correlation between contrast signal intensity and RCE, and
the latter may be less influenced by technical characteristics of
the MR equipment, only RCE was introduced in the regression
analyses.
The only MR findings that were independent predictors of
the presence of active disease at endoscopy, with either mild or
severe lesions, were wall thickness (p,0.001) and RCE
(p = 0.013). The accuracy of a score based on these variables
to predict active disease was high, with an area under the ROC
curve of 0.89 (fig 4A), and sensitivity and specificity .0.8. We
performed an internal validation of the model by bootstrapping,
and in 997 replications of random sampling the frequency of
occurrence of wall thickness as a predictor was 100% and that of
RCE 54%.
Logistic regression analysis showed that independent pre-
dictors of the presence of ulcers at endoscopy were wall
thickness (p,0.001), RCE (p = 0.03) and identification of ulcers
at MR (p = 0.003). The accuracy of a score based on these
variables to predict the presence of ulcerations at endoscopy was
high, with an area under the ROC curve of 0.97 (fig 4B),
sensitivity of 0.9 and specificity of 0.94. Bootstrapping analysis
showed that the predictors were robust, confirming all the
variables from logistic regression, with wall thickness appearing
in 91%, presence of ulcer at MR in 73% and RCE in 57% of the
replications.
Since data distribution for CDEIS of segments was not
normal, with 60% of segments having no significant lesions, a
tobit regression analysis was applied. This analysis demon-
strated that independent predictors for CDEIS are wall
thickness (p = 0.007), RCE (p = 0.01), presence of oedema
(p = 0.02) and presence of ulcers at MR (p = 0.003). There was
a high and significant correlation coefficient between the CDEIS
of the segment and the MR index calculated according to the
logistic regression analysis coefficients (r = 0.82, p,0.001).
From the latter analysis we derived a simplified score
(Magnetic Resonance Index of Activity) to quantify disease
activity based on MR findings in each segment as follows:
MRIA (segment) = 1.56wall thickness
(mm)+0.026RCE+56oedema+106ulceration.
The calculated simplified MRIA index also has a high
(r = 0.81) and significant (p,0.001) correlation with the
CEDEIS of the corresponding segment. The simplified MRIA
in fact had a high correlation (r = 0.997) with the index
calculated directly from the truncated logistic regression.
MRIA range was 3.4–35.0; the index has a high accuracy for
the detection of disease activity (area under the ROC curve
0.891, sensitivity 0.81, specificity 0.89, using a cut-off point of
7.3) and for the detection of ulcerative lesions (area under the
ROC curve 0.978, sensitivity 0.95, specificity 0.91, using a cut-
off point of 9.6) in the colon and terminal ileum.
Comparison of MR and other measures of disease activity
A global MRIA was calculated by adding the values of rectum,
sigmoid, descending, transverse and ascending colon and ileum.
A significant correlation of the global MRAI index was observed
with CDEIS (r = 0.78, p,0.001) (fig 5), Harvey–Bradshaw index
(r = 0.56, p,0.001) and CRP (r = 0.53, p,0.001). Correlations of
CDEIS with the Harvey–Bradshaw index (r = 0.59, p,0.001)
and CRP (r = 0.42, p,0.01) were of similar magnitude to those
of the MRAI index.
DISCUSSION
In this prospective study we provide evidence that the
magnitude of quantitative MR changes such as wall thickening,
contrast signal intensity and RCE closely parallel the severity of
endoscopic lesions; and also the presence of oedema, ulcers,
enlarged lymph nodes and pseudopolyps is significantly more
prevalent in intestinal segments with more severe endoscopic
lesions. This allowed the creation of an MR index of activity
composed of the factors with independent predictive value that
has a high accuracy for the detection of disease activity and
presence of ulceration and is highly correlated with CDEIS.
MR technical advances including ultra-high-field strength
body MR, capability of providing fast multiplanar images with
excellent soft tissue contrast, requirement for minimally
invasive procedures, and lack of radiation exposure allowing
repeated assessments over time render MR a potentially
Table 2 Clinical and biological characteristics of patients at inclusion in
the study
Female, n (%) 27 (54)
Age at diagnosis, median (IQR) 26 (20–35)
Disease duration (years), median (IQR) 6 (2–11)
Disease location
Ileal, n (%) 11 (22)
Ileocolonic, n (%) 24 (48)
Colonic, n (%) 15 (30)
Associated upper GI lesions 5 (10)
Perianal involvement, n (%) 12 (24)
Harvey–Bradshaw index, median (IQR) 7 (3–11)
Harvey–Bradshaw index .4, n (%) 35 (70)
Previous surgery, n (%) 15 (30)
Concomitant treatments
5-ASA, n (%) 10 (20)
Steroids, n (%) 16 (32)
Immunosuppressants, n (%) 24 (48)
Anti-TNF antibodies, n (%) 5 (10)
CRP (mg/l), median (IQR) 19.5 (5.0–77.5)
CDEIS, median (IQR) 6.68 (2.47–13.98)
CDEIS ,3.5/3.5–7/.7, n (%) 13 (26)/12 (24)/25 (50)
5-ASA, 5-acetylsalicylic acid; CDEIS, Crohn’s Disease Endoscopic Index of Severity;
CRP, C-reactive protein; GI, gastrointestinal; IQR, interquartile range; TNF, tumour
necrosis factor.
Table 3 Prevalence of qualitative magnetic resonance findings
according to endoscopic severity of colonic lesions
Normal mucosa
Non-ulcerative
lesions* Ulceration
No 130 43 40
Oedema{ 0% 20.9% 77.5%
Ulcers{ 0% 7.0% 65.0%
Pseudopolyps{ 1.5% 4.7% 27.5%
Enlarged lymph
nodes{
0.8% 7.0% 22.5%
*Non-ulcerative lesions include erythema, oedema, pseudopolyps and aphtae.
{Comparison of proportions p,0.001 x2 test.
Inflammatory bowel disease
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valuable technique for evaluation of patients with CD.14–17
Previous studies in patients with CD have predominantly
evaluated the diagnostic potential of MR for small bowel
lesions, showing promising results. However, data regarding the
diagnostic accuracy of MR for colonic lesions are so far scarce
and controversial. Whereas results reported by Narin et al9 and
Ajaj et al5 provide an acceptable concordance of findings
between MR and endoscopy for the detection of disease activity
(sensitivity of 87–89% and specificity of 85–100%), Schreyer et
al8 and Dintel et al6 reported only discrete results (sensitivity of
Figure 1 Changes in quantitative
magnetic resonance (MR) parameters
according to endoscopic severity of
colonic lesions. Wall thickness (A), post-
ontrast wall signal intensity (C) and
relative contrast enhancement (D) were
significantly increased in parallel with the
severity of endoscopic lesions. Basal
signal intensity (B) was not influenced by
inflammatory lesions. *p,0.01.
w/o, without.
Figure 2 (A) Magnetic resonance axial
T2-wedged depicts moderate wall
thickening of the ascending colon
(arrowheads) that also has a hypersignal
relative to the psoas muscle (arrow)
indicating the presence of oedema.
(B) Coronal T1-VIBE (volumetric
interpolated breath-hold examination)
after intravenous contrast administration.
Marked enhancement of the sigmoid
colon and descending colon (arrows)
relative to the remaining colon can be
seen. Also note the presence of the
irregularity of the mucosal surface
showing ulcers and inflammatory
pseudopolyps.
Inflammatory bowel disease
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32–64% and specificity of 81–100%), suggesting that the
technique may not be adequate for evaluation of CD lesions.
Discrepancy between these results can be partially explained on
the basis of technical aspects. The study of Schreyer et al
employed the ‘‘bright lumen’’ MR technique, using a rectal
enema of gadolinium that produces a hypersignal on both T1
and T2 sequences and can partially mask the enhancement and
mural thickening of the colonic wall. More recently, ‘‘dark
lumen’’ MR is increasingly applied, as we did in the current
study. Using a water rectal enema produces intraluminal
hypointensity on T1 sequences, achieving a high contrast with
a bright bowel wall after intravenous contrast administration.
In two studies, Dintel et al6 and Langhorst et al7 evaluated the
inflammatory changes in the colon using ‘‘dark lumen’’ MR but
without bowel cleansing; this can hamper the identification of
inflammatory changes due to difficulties in establishing precise
measurements of wall thickness and obscuring the presence of
ulcerations. Similar to our study, Narin et al9 and Ajaj et al5
applied ‘‘dark lumen’’ MR with bowel cleansing to evaluate the
colon in CD, showing in both cases a high accuracy of MR for
the detection of lesions. However, both trials included a
relatively small number of patients, and made only a qualitative
analysis of MR findings. Considering our results together with
previous evidence, we suggest that dark lumen MR with bowel
cleansing is probably the current best choice to evaluate
inflammatory changes in the colon using this imaging modality.
The optimal timing of data acquisition for MR colonography is
somewhat controversial. We begin the acquisition 70 s after the
initiation of the bolus, based on previously reported studies.5 18
This phase allows assessment of mucosal and mural enhance-
ment as well as visualisation of abdominal viscera. Others have
suggested an enterography phase (,45 s after bolus injection)
for better detection of mucosal enhancement, but it seems that
this provides no contribution to the assessment of CD activity.19
An aspect that may have contributed to the high diagnostic
accuracy in our study is the use of a 3.0 T MR unit. The images
obtained with 3.0 T have a better signal and higher spatial
resolution than those obtained with 1.5 T, contributing to
increasing the sensitivity for lesion detection.17 20 Some artefacts
are associated with the use of a 3.0 T MR unit, in particular
magnetic susceptibility artefacts that appear on T2 sequences in
the presence of paramagnetic objects (eg, surgical suture in
ileocolic anastomosis). Nevertheless, these artefacts do not
usually represent a limitation for evaluation of potential
inflammatory changes because the extension of the inflamma-
tory tissue is larger than the artefact. Also, an additional
Figure 3 Sagital T1-VIBE (volumetric
interpolated breath-hold examination)
after intravenous contrast administration
of the descending colon and splenic
flexure showing discontinuous lesions
with segmental thickening of the colon
wall and deep ulcers (arrowheads)
alternating with a segment without
inflammatory changes (arrow) (A);
colonoscopy of the same segment shows
the presence of deep ulcers in the
mucosa (B).
Figure 4 Receiver operating
characteristic (ROC) curves, of a
magnetic resonance-based index to
predict presence of active disease (A) and
presence of ulcerative lesions (B) in
Crohn’s disease.
Inflammatory bowel disease
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measure to reduce susceptibility artefacts is the use of fast turbo
spin-echo T2 sequences (eg, HASTE).21
Both MR and CT techniques emerge as excellent techniques
to assess inflammatory activity and detection of extraintestinal
complications in CD.2 14 22–24 CT provides a better spatial
resolution than MR, has greater availability and is less time
consuming. However, MR provides better soft tissue contrast
and uses non-ionising radiation. It has been estimated that CT
examinations account for most of the irradiation exposure in
patients with IBD.3 25The long-term cumulative effect of this
radiation in combination with co-exposure to potentially
synergistic agents such as methotrexate may increase the risk
of neoplasia in these patients.25 Finally, as for MR, studies on
the accuracy of CT in the evaluation of CD focused on the
detection of lesions in the small bowel. The only prospective
study evaluating the value of CT for the characterisation of
inflammatory lesions in the colon suggests a limited sensitivity
of CT, although only the mucosal alterations, and not wall
thickness and contrast enhancement, were considered.26
Doppler ultrasonography represents another non-ionising
imaging technique which may provide information about
disease activity.27 28 However, the difficulty of visualisation of
deep bowel segments and high interobserver variability repre-
sent significant drawbacks. Finally, 99mTc hexamethyl-propy-
lamine-oxim leucocyte scintigraphy is a non-invasive technique,
but radiation exposure and limited sensitivity, especially in
patients receiving steroid treatment, are leading to a reduced
used of this technique.29
MR examination of the small bowel requires oral luminal
contrast to achieve adequate distension. MR enteroclysis allows
better small bowel distention than MR follow-through.
However, nasojejunal tube placement entails radiation exposure
and produces discomfort, and consequently movement artefacts
are more frequent. The only study comparing both modalities
concluded that bowel distension was inferior in MR follow-
through, but diagnostic accuracy was similar in both methods.30
In our study, oral ingestion of the luminal contrast provided
adequate distension of the distal ileum, the segment we
compared with endoscopy. MR enteroclysis might be necessary
in selected cases in which upper CD lesions are suspected and
adequate distension is not achieved with oral administration of
the luminal contrast.
Because the location of CD lesions in the intestine has a
characteristic skip pattern, in which segments with severe
ulcerative lesions can be adjacent to others with normal
mucosa, we evaluated the MR findings associated with lesions
of different endoscopic severity in a segment by segment
analysis as in previous studies4 8 24 and also as a global MR index
of activity. MR changes found to be associated with disease
activity and severity in the current study include oedema,
presence of ulcers, wall thickening and RCE. In our study, these
four parameters were independent predictors of the presence
and severity of disease activity. This finding is in keeping with
previous studies focused mainly on the small intestine.5 14 31 32
Mural oedema is a characteristic feature of active inflammation
of the bowel wall, and can be detected as an increase of signal
on T2-wedged sequences. In severe involvement, odema can
extend to the mesentery. Mural thickening is well correlated
with the presence of activity and with severity. Using a three-
dimensional VIBE sequence, wall thickening can be evaluated at
any plane of space. Based on both bowel wall thickening and
RCE, inflammatory changes can be detected with great accuracy
and played a dominant role in the detection of bowel
inflammation.
Other parameters previously related to inflammatory changes
include enlarged mesenteric lymph nodes and loss of haustra
folds.4 5 We did not include haustra length in our analysis
because of its variability between the proximal and distal colon.
Also, long-standing CD can induce shortening of colonic
haustra secondary to fibrosis in the submucosa.33 The presence
of enlarged lymph nodes has great variability depending on the
anatomic location and patient age (more frequent in the young
population).34 Additionally, prevalence of enlarged lymph nodes
in our series was low.
Demonstration of the high accuracy of MR in detecting the
presence of disease activity and differentiating the presence or
absence of ulcers is of considerable clinical relevance given the
prognostic implications of the presence or persistence of
ulcerative lesions in terms of disease course and surgical
requirements.35 The MRIA we propose in the current study
may be useful to categorise disease severity in a given patient,
and to monitor responses to therapeutic interventions both in
the clinical setting and in therapeutic trials.
One of the limitations of the current study is the lack of
validation of the results in an independent cohort. While these
results are not available, we provide an internal validation of the
results using bootstrapping. The variables that were indepen-
dent predictors of the presence of disease activity or the
presence of ulcerations were validated by this approach. Also,
the magnitude of changes in MRIA in response to treatment
and their correlation with changes in the CDEIS need to be
characterised in future studies. Furthermore, development of an
effective tagging method will probably improve the patient
acceptance of MR since one of the main drawbacks of the
technique is the need for bowel cleansing.
Overall, the results provided in the current study lead to the
suggestion that MR may be considered as an alternative to
endoscopy in cases with an established diagnosis of ileocolonic
CD in which biopsy samples are not necessary. MR has
significant advantages over colonoscopy, including the ability
provide a complete assessment of the ileocolonic region in all
patients, as compared with 72% of complete ileocolonoscopies
in our series, a proportion very similar to previous observations.
As performed in our study, administration of oral contrast and
Figure 5 Correlation between the Crohn’s Disease Endoscopic Index of
Severity (CDEIS) and the global Magnetic Resonance Index of Activity
(MRIA).
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an enema for MR may produce slight discomfort in some
patients, but anaesthesia is not required as for ileocolonoscopy.
The possibility of identifying inflammatory lesions in all
locations of the gastrointestinal tract, and also extraluminal
complications, in just one examination represents a clear
advantage of MR over colonoscopy for evaluation of CD.
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